SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-366818
Filing Date
2015-11-05
Accepted
2015-11-05 06:04:13
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d31694d10q.htm 10-Q 215552
2 EX-3.1 d31694dex31.htm EX-3.1 17555
3 EX-31.1 d31694dex311.htm EX-31.1 8785
4 EX-31.2 d31694dex312.htm EX-31.2 8999
5 EX-32 d31694dex32.htm EX-32 3984
  Complete submission text file 0001193125-15-366818.txt   1831541

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pvct-20150930.xml EX-101.INS 234900
7 XBRL TAXONOMY EXTENSION SCHEMA pvct-20150930.xsd EX-101.SCH 32637
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20150930_cal.xml EX-101.CAL 30132
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20150930_def.xml EX-101.DEF 90573
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20150930_lab.xml EX-101.LAB 243133
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20150930_pre.xml EX-101.PRE 152166
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 151198629
SIC: 2834 Pharmaceutical Preparations